Edwards Lifesciences EW
NYSE EW
$86.16 -0.56 (-0.65%)
As of: Sep 9, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) Cash & Equivalents Growth (5y) (2014 - 2026)

Analysis

Edwards Lifesciences (EW) Cash & Equivalents Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.23%
Mar 31, 2026 15.80%
Dec 31, 2025 19.95%
Sep 30, 2025 21.27%
Jun 30, 2025 29.36%
Mar 31, 2025 36.49%
Dec 31, 2024 20.90%
Sep 30, 2024 25.38%
Jun 30, 2024 17.74%
Mar 31, 2024 11.54%
Dec 31, 2023 9.66%
Sep 30, 2023 2.26%
Jun 30, 2023 -3.20%
Mar 31, 2023 -6.59%
Dec 31, 2022 -1.24%
Sep 30, 2022 14.64%
Jun 30, 2022 18.71%
Mar 31, 2022 4.70%
Dec 31, 2021 -1.49%
Sep 30, 2021 18.50%